Bendroflumethiazide

Country: Нови Зеланд

Језик: Енглески

Извор: Medsafe (Medicines Safety Authority)

Активни састојак:

Bendroflumethiazide 2.5mg;  ;  

Доступно од:

Ipca Pharma (NZ) Pty Limited

INN (Међународно име):

Bendroflumethiazide 2.5 mg

Дозирање:

2.5 mg

Фармацеутски облик:

Tablet

Састав:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

Јединице у пакету:

Blister pack, PVC/PVDC, 14 tablets

Класа:

Prescription

Тип рецептора:

Prescription

Произведен од:

Ipca Laboratories Limited

Терапеутске индикације:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Резиме производа:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

Датум одобрења:

2006-06-28